missing translation for 'onlineSavingsMsg'
Learn More

Kallikrein 5 Mouse anti-Human, Clone: KLK5/3843, Novus Biologicals™

Mouse Monoclonal Antibody

484.00€

Specifications

Antigen Kallikrein 5
Clone KLK5/3843
Concentration 0.2 mg/mL
Dilution Immunohistochemistry-Paraffin 1 to 2 μg/mL, Protein Array
Applications Immunohistochemistry (Paraffin), Peptide Array
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18619766
View Documents
Novus Biologicals
NBP3-07859-100ug
100 μg
484.00€
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Kallikrein 5 Monoclonal specifically detects Kallikrein 5 in Human samples. It is validated for Immunohistochemistry-Paraffin, Protein Array.
Specifications

Specifications

Kallikrein 5
0.2 mg/mL
Immunohistochemistry (Paraffin), Peptide Array
Unconjugated
Mouse
Cancer
10 mM PBS with 0.05% BSA
25818
IgG2b κ
Protein A or G purified
KLK5/3843
Immunohistochemistry-Paraffin 1 to 2 μg/mL, Protein Array
Monoclonal
Purified
RUO
Human
EC 3.4.21, EC 3.4.21.4, kallikrein 5, Kallikrein-like protein 2, kallikrein-related peptidase 5, KLKL2, KLK-L2EC 3.4.21.-, SCTEkallikrein-5, Stratum corneum tryptic enzyme
Recombinant fragment of human Kallikrein 5 protein (around aa 36-177) (exact sequence is proprietary)
Primary
Store at 4°C.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.